Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Current Deferred Revenue (2018 - 2025)

Inventiva (IVEVF) posted Current Deferred Revenue of $1.2 million for Q2 2025, up 36584.79% on a QoQ basis from $3230.7 in Q2 2024, and up 36584.79% year-over-year from N/an in Q2 2024.

Analysis

Inventiva (IVEVF) Current Deferred Revenue (2018 - 2025) Analysis & Trends

Inventiva has reported Current Deferred Revenue for 5 years, with the latest figure at $1.2 million in Q2 2025.

  • On a quarterly basis, Current Deferred Revenue rose 36584.79% year-over-year to $1.2 million in Q2 2025; TTM through Jun 2025 was $1.2 million, a 36584.79% increase from a year earlier, with the FY2023 full-year figure at $6455.6, down 100.0% from the prior year.
  • Current Deferred Revenue was $1.2 million for Q2 2025 at Inventiva, up from $3230.7 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $56.1 billion in Q4 2022, with the low at $3230.7 in Q2 2024.
  • Average Current Deferred Revenue over 4 years is $9.4 billion, with a median of $480774.6 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue plunged 100.0% in 2023, then jumped 36584.79% in 2025.
  • Over 4 years, Current Deferred Revenue stood at $56.1 billion in 2022, then sank by 100.0% to $6455.6 in 2023, then slumped by 49.96% to $3230.7 in 2024, then surged by 36584.79% to $1.2 million in 2025.
  • The last three Current Deferred Revenue figures came in at $1.2 million (Q2 2025), $3230.7 (Q2 2024), and $6455.6 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.19 Mn
Jun 30, 2024 3,230.66
Dec 31, 2023 6,455.64
Jun 30, 2023 6,533.55
Dec 31, 2022 56.11 Bn
Jun 30, 2022 955,015.74
Dec 31, 2018 625,485.24